terazosin

Product NDC
71335-9607
11-digit product format
713359607
Labeler code
71335
Product ID
71335-9607_ff1d7383-5600-487f-b66e-4c2eef397eaf
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
terazosin
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075614
Marketing category
ANDA
Marketing start
2021-04-30
Substance
TERAZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
D32S14F082TERAZOSIN HYDROCHLORIDE70024-40-7TERAZOSIN HYDROCHLORIDE
8L5014XET7TERAZOSIN63590-64-7terazosin

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71335-9607-17133596070130 CAPSULE in 1 BOTTLE (71335-9607-1) 30 capsule2022-12-20NoNoHistorical
71335-9607-27133596070228 CAPSULE in 1 BOTTLE (71335-9607-2) 28 capsule2022-12-20NoNoHistorical
71335-9607-37133596070390 CAPSULE in 1 BOTTLE (71335-9607-3) 90 capsule2022-12-20NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Terazosin Capsules, USPBryant Ranch Prepack2023-11-27HUMAN PRESCRIPTION DRUG LABEL101